Axial involvement in psoriatic arthritis by E. E. Gubar, T. V. Korotaeva

Get full text

THE EARLY DIAGNOSIS AND CLINICAL FEATURES OF AXIAL SPONDYLOARTHRITIS AT THE EUROPEAN CONGRESS OF RHEUMATOLOGY 2015 by E. E. Gubar, Sh. F. Erdes

Get full text

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS by E E Gubar', A G Bochkova, N V Bunchuk, E E Gubar, A G Bochkova, N V Bunchuk

Get full text

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS by E. E. Gubar, E. Yu. Loginova, T. V. Korotaeva

Get full text

Involvement of the axial skeleton in psoriatic arthritis by E. E. Gubar, E. Yu. Loginova, T. V. Korotaeva

Get full text

SRAVNENIE TROYNOY KOMBINIROVANNOY TERAPII METOTREKSATOM, SUL'FASALAZINOM I GIDROKSIKhLOROKhINOM S MONOTERAPIEY METOTREKSATOM PRI REVMATOIDNOM ARTRITE (PREDVARITEL'NYE DANNYE) by E E Gubar', А Г Бочкова, N V Bunchuk

Get full text

Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid... by E E Gubar', A G Bochkova, N V Bunchuk

Get full text

Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, S. I. Glukhova

Get full text

The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection by E. E. Gubar, T. V. Korotaeva, A. S. Starkova, M. M. Urumova

Get full text

Characteristics of patients with psoriatic arthritis treated with ustekinumab. Evidence from real-life clinical practice by Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, T. V. Korotaeva

Get full text

Experience in using secukinumab in patients with axial psoriatic arthritis by E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, T. V. Korotaeva

Get full text

Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis) by E. E. Gubar, E. Yu. Loginova, T. V. Korotaeva, S. I. Glukhova, E. L. Nasonov

Get full text

Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis by E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, S. I. Glukhova, T. V. Korotaeva

Get full text

EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE by E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, P. L. Karpova, T. V. Korotaeva

Get full text

Psoriatic arthritis. Clinical guidelines for diagnosis and treatment by T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, M. N. Chamurlieva

Get full text

2-years outcomes of the treat-to-target strategy in early psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, P. O. Tremaskina, S. I. Glukhova, E. L. Nasonov

Get full text

CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF AXIAL LESION IN EARLY PERIPHERAL PSORIATIC ARTHRITIS (DATA OF A REMARCA STUDY) by E. E. Gubar, E. Yu. Loginova, A. V. Smirnov, S. I. Glukhova, T. V. Korotaeva, E. L. Nasonov

Get full text

Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients by E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, A. V. Smirnov, S. I. Glukhova, T. V. Korotaeva

Get full text

Validation of the PsAID-12 Russian questionnaire in patients with psoriatic arthritis by L. D. Vorobyeva, E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, P. O. Tremaskina, T. V. Korotaeva

Get full text

Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice by L. D. Vorobyeva, T. V. Korotaeva, E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, E. L. Nasonov

Get full text